Ultrasound Estimation of Spleen Size

Sponsor
University of British Columbia (Other)
Overall Status
Completed
CT.gov ID
NCT01810419
Collaborator
(none)
16
1
1
12
1.3

Study Details

Study Description

Brief Summary

In internal medicine, assessment of spleen size on physical examination is an extremely important part of the overall evaluation of patients with many illnesses. Examination of the spleen is also one of the core competencies that the investigators expect our students and residents to learn as part of their training. Unfortunately, the sensitivity and specificity of examination of the spleen at the bedside is not very good. The investigators wish to determine if handheld ultrasound can accurately assess spleen size. Doing so would make physical examination of the spleen obsolete and transform training objectives for medical students and residents.

Condition or Disease Intervention/Treatment Phase
  • Device: Vscan Ultrasound (GE Healthcare, USA)
  • Device: Conventional Ultrasound
N/A

Detailed Description

The diagnosis of splenomegaly (abnormal enlargement of the spleen) is extremely important in managing patients with many medical conditions. The ability to recognize an enlarged spleen in a timely manner can impact patient outcomes. Although the physical exam can be used to confidently diagnosis massive enlargement of the spleen, evaluating lesser degrees of splenomegaly at the bedside proves more difficult. In current practice, the gold standard for diagnosis of splenomegaly is the standard abdominal ultrasound. The prevalence of splenomegaly in patients with several medical conditions such as blood disorders and cirrhosis is relatively high. Therefore, the demand for abdominal ultrasound is evergrowing and similarly the cost of caring for patients with these diseases increases.

Examination of the spleen is one of the core competencies that we expect our students and residents to learn as part of their training. This physical diagnosis manoeuver is frequently used to examine residents at the Royal College level and determine their fitness to practice. Unfortunately, the sensitivity and specificity of examination of the spleen at the bedside is not very good.

With the introduction of handheld ultrasound (HCU) devices, rapid bedside assessment of a patient is now possible. The Pocket-sized Vscan Ultrasound device (Vscan) (GE Healthcare, USA) allows for 2D imaging on a 3.5 inch display and has been shown to have comparable image quality to standard ultrasound for some applications. The Vscan and other HCU devices have been used at point of care to evaluate a number of conditions and can greatly impact treatment decisions in medical patients at the bedside. The ability to recognize splenomegaly in a timely manner can impact patient outcomes. In addition, the use of this technology could significantly impact training standards for students and residents.

It remains unclear whether bedside evaluation with the Vscan is able to accurately measure spleen size. Our study aims to determine the diagnostic accuracy of the Vscan when used by trained ultrasonographers, in patients with varying degrees of splenomegaly. If we can reliably show that a trained ultrasonographer can accurately characterize spleen size at the bedside with a handheld device, the next stage of the study will involve training medical residents in the use of handheld ultrasound to see if they can also reliably assess spleen size.

Study Design

Study Type:
Interventional
Actual Enrollment :
16 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Estimation of Spleen Size With Hand Held Ultrasound
Study Start Date :
Mar 1, 2013
Actual Primary Completion Date :
Oct 1, 2013
Actual Study Completion Date :
Mar 1, 2014

Arms and Interventions

Arm Intervention/Treatment
Experimental: normal and various degrees splenomegaly

Vscan Ultrasound (GE Healthcare, USA) Conventional Ultrasound (Ultrasonix) used to determine spleen size Crossover design, all subjects will be measured with both devices. half will have the handheld done first, then conventional half the Conventional done first, then handheld Will complete questionaire for both: Adequacy of image quality What is best view obtained Greatest Longitudinal Measure Diagnosis Diagnostic Certainty Time to Complete exam

Device: Vscan Ultrasound (GE Healthcare, USA)
Vscan Ultrasound used to determine spleen size and the other qualities described in the arm description.
Other Names:
  • handheld ultrasound (HCU)
  • Device: Conventional Ultrasound
    Conventional Ultrasound used to determine spleen size and the other qualities described in the arm description.
    Other Names:
  • Gold standard
  • standard ultrasound
  • Ultrasonix
  • Outcome Measures

    Primary Outcome Measures

    1. longitudinal measure of spleen in centimeters [1 day]

    Secondary Outcome Measures

    1. Diagnosis of spleen size [1 day]

      Diagnosis No Splenic Enlargement Moderate Splenic Enlargement Massive Splenic enlargement

    2. time to complete Vscan examination [1 day]

      Time to complete Vscan exam <5min 5-10 min 10-15min >15min

    Other Outcome Measures

    1. Image quality and best views [1 day]

      Adequacy of study Image quality inadequate to make diagnosis Image quality adequate Image quality excellent Best Views obtained Supine Right Lateral Decubitus

    2. Diagnostic Certainty [1 day]

      Diagnostic Certainty Not confident Somewhat confident Very confident

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • patients in the practices of hematologists at VGH (Vancouver General Hospital) who are expected to have normal size spleens as well as various degrees of splenomegaly
    Exclusion Criteria:
    • will exclude patients who cannot speak English or who cannot give informed consent

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Vancouver Coastal Health (VCHRI/VCHA) Vancouver British Columbia Canada V5Z 1M9

    Sponsors and Collaborators

    • University of British Columbia

    Investigators

    • Principal Investigator: Graydon S Meneilly, MD, University of British Columbia

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Graydon Meneilly, MD, FRCPC, FACP, Professor & Eric W. Hamber Chair, University of British Columbia
    ClinicalTrials.gov Identifier:
    NCT01810419
    Other Study ID Numbers:
    • H12-03055
    First Posted:
    Mar 13, 2013
    Last Update Posted:
    Apr 14, 2017
    Last Verified:
    Apr 1, 2017
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Keywords provided by Graydon Meneilly, MD, FRCPC, FACP, Professor & Eric W. Hamber Chair, University of British Columbia
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Apr 14, 2017